Functional sequelae in COVID-19 survivors hospitalized in a Specialized Center in Costa Rica, July-December 2020

Main Article Content

Lilem Valerio-Gil https://orcid.org/0000-0003-1005-3520
María José Gallardo-Arriagada https://orcid.org/0000-0002-5178-447X

Keywords

COVID-19, SARS-CoV-2, rehabilitation, functional capacity, disability

Abstract

Objective: This study aims to describe the demographic and clinical profiles, as well as the functional sequelae, in COVID-19 survivor patients who were hospitalized at CEACO between July and December 2020. Methods: A retrospective observational study was conducted on patients who underwent multidisciplinary follow-up evaluations at CENARE. Data were collected through the review of clinical records. Descriptive statistics and frequency distributions were employed for data analysis. Additionally, multivariate logistic models were used to assess the association between severity factors and subsequent sequelae. Data processing was performed using the R program in conjunction with the Tidyverse package. Results: Data from a total of 310 patients were meticulously analyzed. Among these, 93.70% were of Costa Rican nationality. The male population accounted for 62%, with an average age of 61 years. Pre-existing conditions were prevalent, with 58% of patients having hypertension and 61% diagnosed with type 2 diabetes mellitus. Furthermore, 71.28% were categorized as obese based on their body mass index. The average length of hospital stay was determined to be 12.47 days. Notably, the predominant respiratory device used was the high-flow nasal cannula. Concerning post-hospitalization status, 70.65% of patients were discharged with a rehabilitation risk level B, undergoing assessment for an average period of 26.91 days at CENARE. Specific post-COVID-19 sequelae included dyspnea in 27.72% of individuals, muscular strength impairment in 7.1% of the cohort, and psychoemotional sequelae in 17%. Furthermore, a risk of malnutrition was identified in 10% of cases. Logistic regression models demonstrated a direct correlation between prolonged hospital stays, malnutrition risk, and the likelihood of experiencing dyspnea and reduced muscular strength. Conclusion: This comprehensive analysis substantiates the presence of functional sequelae among individuals who have battled COVID-19.

Abstract 471 | PDF (Español (España)) Downloads 239

References

1. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581-586.

2. Williams N. The MRC breathlessness scale. Occup Med. 2017;67:496-497.

3. Bagnato S, Boccagni C, Marino G, Prestandrea C, D'Agostino T, Rubino F. Critical illness myopathy after COVID-19. Int J Infect Dis. 2020;99:276-278.

4. McClafferty B, Umer I, Fye G, Kepko D, Kalayanamitra R, Shahid Z, et al. Approach to critical illness myopathy and polyneuropathy in the older SARS-CoV-2 patients. J Clin Neurosci. 2020;79:241-245.

5. Hokkoku K, Erra C, Cuccagna C, Coraci D, Gatto DM, Glorioso D, et al. Intensive Care Unit-Acquired Weakness and Positioning-Related Peripheral Nerve Injuries in COVID-19: A Case Series of Three Patients and the Latest Literature Review. Brain sci. 2021;11:1-11.

6. Caamaño L, Fuentes D, González L, Melipillán R, Sepúlveda M, Valenzuela E. Adaptación y validación de la versión chilena de la escala de impacto de evento-revisada (EIE-R). Rev. méd. Chile. 2011;139:1163-1168.

7. Gil F, Costa G. Propiedades psicométricas de la escala revisada del impacto del evento estresante (IES-R) en una muestra española de pacientes con cáncer. Anál. Modif. Conduct. 2007;33:311-331.

8. Hoyl T, Valenzuela E, Marín P. Depresión en el adulto mayor: evaluación preliminar de la efectividad, como instrumento de tamizaje, de la versión de 5 ítems de la Escala de Depresión Geriátrica. Rev. Méd Chile. 2000;128:1199-1204.

9. Benedetti A, Wu Y, Levis B, Wilchesky M, Boruff J, Ioannidis JPA, et al. Diagnostic accuracy of the Geriatric Depression Scale-30, Geriatric Depression Scale-15, Geriatric Depression Scale-5 and Geriatric Depression Scale-4 for detecting major depression: protocol for a systematic review and individual participant data meta-analysis. BMJ Open. 2018;8:1-6.

10. Turan Z, Topaloglu M, Ozyemisci-Taskiran O. Medical Research Council-sumscore: a tool for evaluating muscle weakness in patients with post-intensive care syndrome. Crit Care. 2020;24:1-2.

11. Jang M, Shin M, Shin Y. Pulmonary and Physical Rehabilitation in Critically Ill Patients. Acute Crit Care. 2019;34:1-13.

12. Moreno-Pérez O, Merino E, León-Ramírez JM, Andrés M, Ramos JM, Arenas-Jiménez J, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect. 2021;82:378-383.

13. Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2021;93:1013-1022.

14. Huang C, Huang L, Wang Y, Li X, Ren L, Gu X. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220-232.

15. Carfi A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324:603-605.

16. Hu B, Guo H, Zhou P, Shi Z. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19:141-154.

17. Kumar V, Kumar R, Gupta A, Tejan N. Neuromuscular presentations in patients with COVID-19. Neurol Sci. 2020;41:3039-3056.

18. Gao Y, Ding M, Dong X, Zhang J, Kursat Azkur A, Azkur D, et al. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy. 2021;76:428-455.

19. Goërtz Y, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado F, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?. ERJ open research. 2020;6:1-10.

20. Augustin M, Schommers P, Stecher M, Dewald F, Gieselmann L, Gruell H, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021;6:1-8.

21. Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. 2021;27:89-95.

22. Liu G, Zhang S, Mao Z, Wang W, Hu H. Clinical significance of nutritional risk screening for older adult patients with COVID-19. Eur J Clin Nutr. 2020;74:876-883.

23. Li T, Zhang Y, Gong C, Wang J, Liu B, Shi L, et al. Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China. Eur J Clin Nutr. 2020;74:871-875.

24. Zhang P, He Z, Yu G, Peng D, Feng Y, Ling J, et al. The modified NUTRIC score can be used for nutritional risk assessment as well as prognosis prediction in critically ill COVID-19 patients. Clin Nutr. 2021;40:534-541.

25. Skipper A, Ferguson M, Thompson K, Castellanos V, Porcari J. Nutrition screening tools: an analysis of the evidence. JPEN J Parenter Enteral Nutr. 2012;36:292-298.

26. Cruz V, Bernal L, Buitrago G, Ruiz A. Frecuencia de riesgo de desnutrición según la Escala de Tamizado para Desnutrición (MST) en un servicio de Medicina Interna. Rev. méd. Chile. 2017;145:449-457.

27. Di Sibio, M, Zohar J, Magnífico L, Fischberg M, Ramírez S, Silvia, J. et al. Revisión de diferentes herramientas de tamizaje nutricional para pacientes hospitalizados. Diaeta, 2018;36:30-38.

28. Péramo-Álvarez F, López-Zúñiga M, López-Ruz M. Medical sequels of COVID-19. Med Clin. 2021;157:388-394.

29. Cabañes-Martínez L, Villadóniga M, González-Rodríguez L, Araque L, Díaz-Cid A, Ruz-Caracuel I, et al. Neuromuscular involvement in COVID-19 critically ill patients. Clin Neurophysiol. 2021;131: 2809-2816.

30. Daia C, Scheau C, Neagu G, Andone I, Spanu A, Popescu C, et al. Nerve conduction study and electromyography findings in patients recovering from Covid-19 - Case report. Int J Infect Dis. 2021;103:420-422.